Survival analysis of 19 patients with toxic thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 9, 2002, Pages 4122-4127

  Als, Claudine ^a,b,c   Gedeon, Peter ^a,b,c   Rösler, Helmuth ^a,b,c   Minder, Christoph ^a,b,c   Netzer, Peter ^a,b,c   Laissue, Jean A ^a,b,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Institute of Nuclear Medicine   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RADIOACTIVE IODINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; THYROID CARCINOMA; TOXIC THYROID CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THYROID NEOPLASMS; THYROTOXICOSIS; TIME FACTORS;

EID: 0036736775     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2001-011147     Document Type: Article

References (43)

1. Russo D, Tumino S, Arturi F, Vigneti P, Grasso G, Pontecorvi A, Filetti S, Belfiore A 1997 Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 82:735-738
2. Baloch Z, Livolsi VA 1997 Detection of an activating mutation of the thyrotropin receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma. J Clin Endocrinol Metab 82:3906-3908 (Letter)
3. Arturi F, Russo D, Giuffrida D, Ippolito A, Pernotti N, Vigneri R, Filetti S 1997 Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab 82:1638-1641
4. Filetti S, Bidart JM, Arturi F, Caillou B, Russo D, Schlumberger M 1999 Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 141:443-457
5. Russo D, Manole D, Arturi F, Suarez HG, Schlumberger M, Filetti F, Derwahl M 2001 Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas. Thyroid 11:37-39
6. De la Vieja A, Dohan O, Levy O, Carrasco N 2000 Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol Rev 80:1083-1105
7. - symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab 86:3430-3435
8. Paul SJ, Sisson JC 1990 Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am 19:593-612
9. sα genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 82:2695-2701
10. Russo D, Arturi F, Suarez HG, Schlumberger M, Du Villard JA, Crocetti U, Filetti S 1996 Thyrotropin receptor gene alterations in thyroid hyperfunctioning adenomas. J Clin Endocrinol Metab 81:1548-1551
11. Kopp P 2001 Human genome and diseases: review. The TSH receptor and its role in thyroid disease. Cell Mol Life Sci 58:1301-1322
12. Russo D, Wong MG, Costante G, Chiefari E, Treseler PA, Arturi F, Filetti S, Clark OH 1999 A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis. Thyroid 9:13-17
13. Camacho P, Gordon D, Chiefari E, Yong S, DeJong S, Pitale S, Russo D, Filetti S 2000 A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid 10:1009-1012
14. Mircescu H, Parma J, Huot C, Deal C, Oligny LL, Vassart G, Van Vliet G 2000 Hyperfunctioning malignant thyroid nodule in an 11-year-old girl: pathologic and molecular studies. J Pediatr 137:585-587
15. Liu G, Duranteau L, Carel JC, Monroe J, Doyle DA, Shenker A 1999 Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341:1731-1736
16. Fournes B, Monier R, Michiels F, Milgrom E, Misrahi M, Feunteun J 1998 Oncogenic potential of mutant human thyrotropin receptor expressed in FRTL-5 cells. Oncogene 16:985-990
17. Krohn K, Paschke R 2001 Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 86:3336-3345
18. Dumont JE, Ermans AM, Maenhaut C, Coppée F, Stanbury JB 1995 Large goiter as a maladaptation to iodine deficiency. Clin Endocrinol 43:1-10
19. Horst W, Rösler H, Schneider C, Labhart A 1967 306 cases of toxic adenoma. J Nucl Med 8:515-528
20. Kinser JA, Rösler H, Furrer T, Grütter D, Zimmermann H 1989 Nonimmunogenic hyperthyroidism: cumulative hypothyroidism incidence after radioiodine and surgical treatment. J Nucl Med 30:1960-1965
21. Als C, Listewnik M, Rösler H, Bartkowiak E 1995 Immunogenic and non-immunogenic hyperthyroidism: recent trends in prealpine Switzerland and in coastal Poland. Nuklearmedizin 34:92-99
22. Ermans AM, Camus M 1972 Modifications of thyroid function induced by chronic administration of iodide in the presence of autonomous thyroid tissue. Acta Endocrinol 70:463-475
23. Lorberboym M, Mechanick JI 1996 Accelerated thyrotoxicosis induced by iodinated contrast media in metastatic differentiated thyroid carcinoma. J Nucl Med 37:1532-1535
24. Bürgi H, Kohler M, Morselli B 1998 Thyrotoxicosis incidence in Switzerland and benefit of improved iodine supply (Letter). Lancet 352:1034
25. Als C, Lauber K, Brander L, Lilscher D, Rösler H 1995 The instability of dietary iodine supply over time in an affluent society. Experientia (Basel) 51:623-633
26. Bürgi H, Supersaxo Z, Selz B 1990 Iodine deficiency diseases in Switzerland one hundred years after Theodor Kocher's survey: a historical review with some new goitre prevalence data. Acta Endocrinol 123:577-590
27. Als C, Helbling A, Peter K, Haldimann M, Zimmerli B, Gerber H 2000 Urinary iodine concentration follows a circadian rhythm. A study with 3023 spot urine samples in adults and children. J Clin Endocrinol Metab 85:1367-1369
28. UICC: International Union Against Cancer 1997 TNM classification of malignant tumours, ed 5. In: Sobin LH, Wittekind C, eds. New York, Chichester, Weinheim, Brisbane, Singapore, Toronto: Wiley-Liss
29. Rotman-Pikielny P, Reynolds JC, Barker WC, Yen PM, Skarulis MC, Sarlis NJ 2000 Recombinant human thyrotropin for the diagnosis and treatment of highly functional metastatic struma ovarii. J Clin Endocrinol Metab 85:237-244
30. Rösler H, ed. 1991 EANM task group on therapeutic use of radioisotopes: recommendations for standard protocols on therapy with radioiodine in non-malignant disease of the thyroid. Eur J Nucl Med 18:A11-A13
31. Rösler H, Birrer A, Lüscher D, Kinser J 1992 Long-term course in differentiated thyroid gland carcinoma. Swiss Med Wkly 122:1843-1857
32. Gemsenjäger E 1993 Concerning: "Long-term course in differentiated thyroid carcinoma" by H. Rösler, A. Birrer, D. Luscher and J. Kinser (Swiss Med Wkly 1992; 122: 1843-1857). Swiss Med Wkly 123:658-660 (Letter and reply)
33. Als C, Keller A, Minder C, Haldimann M, Gerber H 2000 Age- and gender-dependent urinary iodine concentrations in an area-covering population sample from the Bernese region in Switzerland. Eur J Endocrinol 143:629-637
34. Fraker DL, Skarnlis M, Livolsi V 1997 Cancer of the endocrine system Section 2. Thyroid tumors. In: De Vita Jr VT, Hellman S, Rosenberg SA, eds. Cancer. Principles and practice of oncology, vol 2, ed 5. Philadelphia, New York: Lippincott-Raven; 1629-1652
35. Thalmann A 1954 Die Häufigkeit der Struma Maligna am Berner Pathologischen Institut von 1910-1950 und ihre Beziehung zur Jodprophylaxe des endemischen Kropfes Swiss Med Wkly 84:473-478
36. Walthard B 1963 Der gestaltwandel der Struma Maligna in Bezug auf die Jodprophylaxe des Kropfes. Swiss Med Wkly 93:809-814
37. Gemsenjäger E, Heitz PU, Seifert B, Martina B, Schweizer I 2001 Differentiated thyroid carcinoma. Follow-up of 264 patients from one institution for up to 25 years. Swiss Med Wkly 131:157-163
38. Gemsenjäger E, Heitz PU, Martina B 1997 Selective treatment of differentiated thyroid carcinoma. World J Surg 21:546-552
39. Levi F, Franceschi S, Te VC, Negri E, La Vecchia C 1990 Descriptive epidemiology of thyroid cancer in the Swiss canton of Vaud. J Cancer Res Clin Oncol 116:639-647
40. Schüller G, Bopp M 1997 C20 Thyroid ICD 193. Atlas of cancer mortality in Switzerland 1970-1990. Volume C. Cancer mortality. Birkhäuser (ed) Basel, Boston, Berlin: Kantonalzürcherisches Krebsregister; 193-200
41. Stanbury JB, Ermans AE, Bourdoux P, Todd C, Oken E, Tonglet R, Vidor G, Braverman LE, Medeiros-Neto G 1998 Iodine-induced hyperthyroidism: occurrence and epidemiology. Thyroid 8:83-100
42. Als C, Rösler H 1995 Toxic adenoma of the thyroid becoming less frequent in Bern. Swiss Med Wkly 31/32:1495-1499
43. Caplan RH, Abellera RM, Kisken WA 1994 Hürthle cell neoplasms of the thyroid gland: reassessment of functional capacity Thyroid 4:243-248